Walter Wenninger

Directeur/Membre du Conseil chez NOXXON Pharma AG

Profil

Walter Wenninger is currently a Member-Supervisory Board at NOXXON Pharma AG since 2015.
Previously, he held positions such as Chairman at Bayer Corp., Deputy Chairman at PAION AG in 2011, Chairman-Supervisory Board at Generali Deutschland Versicherung AG, Vice Chairman-Supervisory Board at Evotec SE from 2014 to 2015, Chairman at Roche Innovation Center Copenhagen A in 2014, and Chairman-Supervisory Board at Epidauros Biotechnologie AG.
He was also Chairman at the German Cancer Research Center from 1994 to 2000 and a Member-Management Board at Bayer AG from 1994 to 2000.
Additionally, he served as an Independent Non-Executive Director at Recordati SpA, Director at 3i Infotech, Inc., and Non-Executive Director at Arrow Therapeutics Ltd. He was also a Trustee at the German Cancer Research Center and a Member-Supervisory Board at TME Pharma NV.
Dr. Wenninger obtained an MBA and a doctorate from Ludwig-Maximilians-Universität München.

Postes actifs de Walter Wenninger

Sociétés	Poste	Début
NOXXON Pharma AG	Directeur/Membre du Conseil	-

Anciens postes connus de Walter Wenninger

Sociétés	Poste	Fin
TME PHARMA N.V.	Directeur/Membre du Conseil	25/06/2019
EVOTEC SE	Président	17/06/2014
Roche Innovation Center Copenhagen A/S	Président	02/09/2014
PAION AG	Directeur/Membre du Conseil	24/05/2011
BAYER AG	Corporate Officer/Principal	01/01/2000